{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:35:02Z","timestamp":1790426102877,"version":"4.1.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bcp.2017.07.016","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T02:47:08Z","timestamp":1500605228000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"C","title":["The therapeutic potential of purinergic signalling"],"prefix":"10.1016","volume":"151","author":[{"given":"Geoffrey","family":"Burnstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.07.016_b0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(24)01373-5","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2017.07.016_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","article-title":"Cellular distribution and functions of P2 receptor subtypes in different systems","volume":"240","author":"Burnstock","year":"2004","journal-title":"Int. Rev. Cytol."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/bph.13429","article-title":"Effects of P2Y12 receptor antagonists beyond platelet inhibition - comparison of ticagrelor with thienopyridines","volume":"173","author":"Nylander","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tips.2016.02.006","article-title":"Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?","volume":"37","author":"Borea","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0030","article-title":"Purinergic signalling: pathophysiology and therapeutic potential","volume":"2","author":"Burnstock","year":"2016","journal-title":"J. Drug Res. Dev."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.083758","article-title":"P2X receptors as drug targets","volume":"83","author":"North","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2017.07.016_b0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2017.07.016_b0045","doi-asserted-by":"crossref","DOI":"10.2174\/1871527315666160922104848","article-title":"Purinergic signalling and neurological diseases: an update","volume":"16","author":"Burnstock","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bcp.2017.07.016_b0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer's disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3892\/mmr.2016.6070","article-title":"Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease","volume":"15","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"19","key":"10.1016\/j.bcp.2017.07.016_b0060","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1093\/hmg\/ddv278","article-title":"A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis","volume":"24","author":"Gu","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.bcp.2017.07.016_b0065","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1242\/dmm.017038","article-title":"Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Apolloni","year":"2014","journal-title":"Dis. Model. Mech."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharep.2016.09.018","article-title":"Role of the purinergic signaling in epilepsy","volume":"69","author":"Cieslak","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bcp.2017.07.016_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2015.05.031","article-title":"An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration","volume":"104","author":"Burnstock","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2017.07.016_b0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-801022-8.00003-9","article-title":"An overview of adenosine A2A receptor antagonists in Parkinson's disease","volume":"119","author":"Jenner","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.bcp.2017.07.016_b0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","article-title":"Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models","volume":"79","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.2015_1004","article-title":"The roles of purinergic signaling in psychiatric disorders","volume":"63","author":"Cieslak","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bcp.2017.07.016_b0095","series-title":"Purinergic Signalling and the Nervous System","author":"Burnstock","year":"2012"},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/omi.2016.0003","article-title":"Adenosine hypothesis of antipsychotic drugs revisited: pharmacogenomics variation in nonacute schizophrenia","volume":"20","author":"Turcin","year":"2016","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0105","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12035-014-9031-z","article-title":"Role of P2X7 receptor in an animal model of mania induced by D-amphetamine","volume":"53","author":"Gubert","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.bcp.2017.07.016_b0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperlagh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2017.07.016_b0115","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/B978-0-12-801022-8.00015-5","article-title":"Involvement of adenosine A2A receptors in depression and anxiety","volume":"119","author":"Yamada","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jnr.23816","article-title":"P2 receptors, microglial cytokines and chemokines, and neuropathic pain","volume":"95","author":"Tsuda","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13543776.2017.1246538","article-title":"P2X7 receptor antagonists: a patent review (2010\u20132015)","volume":"27","author":"Park","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signalling in the cardiovascular system","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22050752","article-title":"The adenosinergic system as a therapeutic target in the vasculature: new ligands and challenges","volume":"22","author":"Sousa","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2017.07.016_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4173","article-title":"Purinergic receptors in the carotid body as a new drug target for controlling hypertension","author":"Pijacka","year":"2016","journal-title":"Nat. Med. Adv."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.molmed.2014.12.008","article-title":"Purinergic signaling in atherosclerosis","volume":"21","author":"Ferrari","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"Suppl_1","key":"10.1016\/j.bcp.2017.07.016_b0155","first-page":"A16502","article-title":"Deficiency of purinergic receptor P2X7 reduces atherosclerosis in mice","volume":"134","author":"Stachon","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jcin.2016.11.021","article-title":"Drug-drug interactions when switching between intravenous and oral P2Y12 receptor inhibitors: how real is it?","volume":"10","author":"Rollini","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11302-016-9521-8","article-title":"Nucleotide homeostasis and purinergic nociceptive signaling in rat meninges in migraine-like conditions","volume":"12","author":"Yegutkin","year":"2016","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bcp.2017.07.016_b0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ijcard.2016.12.089","article-title":"Expressions of adenosine A2A receptors in coronary arteries and peripheral blood mononuclear cells are correlated in coronary artery disease patients","volume":"230","author":"Gariboldi","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2017.07.016_b0180","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1124\/pr.111.005389","article-title":"Purinergic signalling in the airways","volume":"64","author":"Burnstock","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2017.07.016_b0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autneu.2013.12.008","article-title":"Neural regulation of inflammation in the airways and lungs","volume":"182","author":"McGovern","year":"2014","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.bcp.2017.07.016_b0190","article-title":"Critical roles of adenosine A2A receptor in regulating the balance of Treg\/Th17cells in allergic asthma","author":"Wang","year":"2016","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.bcp.2017.07.016_b0195","first-page":"A1394","article-title":"Clinical implication of adenosine triphosphate in sputum in asthma","volume":"193","author":"Soma","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2017.07.016_b0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2017.04.014","article-title":"Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases","volume":"134","author":"Basu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0205","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.chest.2016.06.045","article-title":"Extracellular adenosine 5'-triphosphate in obstructive airway diseases","volume":"150","author":"Pelleg","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2017.07.016_b0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.meegid.2017.05.003","article-title":"Genetic polymorphisms of the P2X7 gene associated with susceptibility to and prognosis of pulmonary tuberculosis","volume":"53","author":"Zheng","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/vim.2016.0008","article-title":"Ionotropic purinergic receptors P2X4 and P2X7: proviral or antiviral? An insight into P2X receptor signaling and hepatitis C virus infection","volume":"29","author":"Manzoor","year":"2016","journal-title":"Viral Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2017.07.016_b0220","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.micinf.2012.04.009","article-title":"Purinoceptor signaling in malaria-infected erythrocytes","volume":"14","author":"Huber","year":"2012","journal-title":"Microbes Infect."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0225","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200607-970OC","article-title":"A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis","volume":"175","author":"Fernando","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/01902148.2017.1286697","article-title":"Lung injury pathways: adenosine receptor 2B signaling limits development of ischemic bronchiolitis obliterans organizing pneumonia","volume":"43","author":"Densmore","year":"2017","journal-title":"Exp. Lung Res."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1096\/fj.15-274845","article-title":"Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis","volume":"30","author":"Luo","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2017.07.016_b0240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.phrs.2013.08.004","article-title":"The role of the adenosinergic system in lung fibrosis","volume":"76","author":"Della Latta","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0245","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.lungcan.2015.10.005","article-title":"Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer","volume":"90","author":"Schmid","year":"2015","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-017-0591-1","article-title":"CD73\/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer","volume":"16","author":"Zhu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"9974","key":"10.1016\/j.bcp.2017.07.016_b0255","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","article-title":"P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study","volume":"385","author":"Abdulqawi","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0260","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/pr.58.1.5","article-title":"Pathophysiology and therapeutic potential of purinergic signaling","volume":"58","author":"Burnstock","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2017.07.016_b0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1358\/dof.2016.041.09.2533858","article-title":"The role of adenosine receptor agonists in ocular disorders","volume":"41","author":"Lee","year":"2016","journal-title":"Drugs Future"},{"key":"10.1016\/j.bcp.2017.07.016_b0270","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neuropharm.2015.05.005","article-title":"Purinergic signaling in retinal degeneration and regeneration","volume":"104","author":"Reichenbach","year":"2016","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0275","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-016-9547-y","article-title":"Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma","volume":"13","author":"Fonseca","year":"2017","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bcp.2017.07.016_b0280","first-page":"327","article-title":"P2Y2 receptor agonists for the treatment of dry eye disease: a review","volume":"8","author":"Lau","year":"2014","journal-title":"Clin. Ophthalmol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4239\/wjd.v5.i2.141","article-title":"Role of P2X7 receptors in the development of diabetic retinopathy","volume":"5","author":"Sugiyama","year":"2014","journal-title":"World J. Diab."},{"key":"10.1016\/j.bcp.2017.07.016_b0290","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2015.10.008","article-title":"P2X7 receptor knockout prevents streptozotocin-induced type 1 diabetes in mice","volume":"419","author":"Vieira","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2017.07.016_b0295","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2016.04.014","article-title":"P2X7-pannexin-1 and amyloid \u03b2-induced oxysterol input in human retinal cell: role in age-related macular degeneration?","volume":"127","author":"Olivier","year":"2016","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.bcp.2017.07.016_b0300","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcp.25274","article-title":"Molecular structure and regulation of P2X receptors with a special emphasis on the role of P2X2 in the auditory system","volume":"231","author":"Mittal","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0305","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbrc.2015.06.050","article-title":"Nucleotide modulates odor response through activation of purinergic receptor in olfactory sensory neuron","volume":"463","author":"Yu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0310","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1113\/jphysiol.2014.281014","article-title":"Postsynaptic P2X3-containing receptors in gustatory nerve fibres mediate responses to all taste qualities in mice","volume":"593","author":"Vandenbeuch","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2017.07.016_b0315","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuropharm.2015.09.019","article-title":"Purinergic mechanisms in neuroinflammation: An update from molecules to behavior","volume":"104","author":"Beamer","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2017.07.016_b0320","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.autneu.2015.04.011","article-title":"Purinergic signaling in the immune system","volume":"191","author":"Di Virgilio","year":"2015","journal-title":"Auton. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nri.2016.4","article-title":"Purinergic regulation of the immune system","volume":"16","author":"Cekic","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0330","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/ATVBAHA.116.307401","article-title":"P2Y12 receptor modulates sepsis-induced inflammation","volume":"36","author":"Liverani","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0335","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2337\/db12-0242","article-title":"Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection","volume":"62","author":"Vergani","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0340","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/2319-4170.127803","article-title":"The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases","volume":"37","author":"Morandini","year":"2014","journal-title":"Biomed. J."},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0345","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bj.2016.09.002","article-title":"Purinergic signaling in infection and autoimmune disease","volume":"39","author":"Savio","year":"2016","journal-title":"Biomed. J."},{"key":"10.1016\/j.bcp.2017.07.016_b0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fcimb.2017.00113","article-title":"P2X1, P2X4, and P2X7 receptor knock out mice expose differential outcome of sepsis induced by \u03b1-haemolysin producing Escherichia coli","volume":"7","author":"Greve","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0355","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.imbio.2016.02.003","article-title":"The purinergic receptor P2X7 role in control of Dengue virus-2 infection and cytokine\/chemokine production in infected human monocytes","volume":"221","author":"Corr\u00eaa","year":"2016","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11302-016-9544-1","article-title":"The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control","volume":"13","author":"Figliuolo","year":"2017","journal-title":"Purinergic Signal."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0365","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bj.2016.06.007","article-title":"Trichomoniasis immunity and the involvement of the purinergic signaling","volume":"39","author":"Menezes","year":"2016","journal-title":"Biomed. J."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0370","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbrc.2015.03.121","article-title":"P2Y purinergic receptor-regulated insulin secretion is mediated by a cAMP\/Epac\/Kv channel pathway","volume":"460","author":"Zhang","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2017.07.016_b0375","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.molmet.2016.09.006","article-title":"Critical role for adenosine receptor A2a in \u03b2-cell proliferation","volume":"5","author":"Schulz","year":"2016","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.bcp.2017.07.016_b0380","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/0886022X.2016.1207054","article-title":"Exogenously administered adenosine attenuates renal damage in streptozotocin-induced diabetic rats","volume":"38","author":"Taskiran","year":"2016","journal-title":"Renal Fail."},{"issue":"16","key":"10.1016\/j.bcp.2017.07.016_b0385","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1111\/bph.13205","article-title":"Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes","volume":"172","author":"Matsumoto","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.07.016_b0390","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.autneu.2016.04.001","article-title":"LncRNA uc.48+ siRNA improved diabetic sympathetic neuropathy in type 2 diabetic rats mediated by P2X7 receptor in SCG","volume":"197","author":"Wu","year":"2016","journal-title":"Auton. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0395","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12576-014-0344-5","article-title":"Contributions of purinergic P2X3 receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain","volume":"65","author":"Guo","year":"2015","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.bcp.2017.07.016_b0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1744-8069-10-37","article-title":"Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain","volume":"10","author":"Ursu","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.bcp.2017.07.016_b0405","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2017.02.017","article-title":"Role of A1 and A2A adenosine receptor agonists in adipose tissue inflammation induced by obesity in mice","volume":"799","author":"DeOliveira","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0410","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.cell.2015.08.032","article-title":"Hypothalamic UDP increases in obesity and promotes feeding via P2Y6-dependent activation of AgRP neurons","volume":"162","author":"Steculorum","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bcp.2017.07.016_b0415","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.4049\/jimmunol.1502506","article-title":"ATP-induced inflammation drives tissue-resident Th17 cells in metabolically unhealthy obesity","volume":"196","author":"Pandolfi","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2017.07.016_b0420","series-title":"The Enteric Nervous System. 30 Years Later","first-page":"91","article-title":"Purinergic signalling in the gut","author":"Burnstock","year":"2016"},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0425","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/MIB.0000000000000047","article-title":"Potential for developing purinergic drugs for gastrointestinal diseases","volume":"20","author":"Ochoa-Cortes","year":"2014","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.bcp.2017.07.016_b0430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fnins.2016.00311","article-title":"Purinergic signaling in gut inflammation: the role of connexins and pannexins","volume":"10","author":"Diezmos","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2017.07.016_b0435","doi-asserted-by":"crossref","first-page":"19108","DOI":"10.1038\/srep19108","article-title":"Extracellular ATP mediates inflammatory responses in colitis via P2 x 7 receptor signaling","volume":"6","author":"Wan","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0440","doi-asserted-by":"crossref","first-page":"705","DOI":"10.18632\/oncotarget.13525","article-title":"MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0445","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bbadis.2017.03.004","article-title":"P2X7 receptor promotes intestinal inflammation in chemically induced colitis and triggers death of mucosal regulatory T cells","volume":"1863","author":"Figliuolo","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bcp.2017.07.016_b0450","first-page":"2247","article-title":"Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn's disease: a randomized placebo-controlled, double-blind, phase IIa study","volume":"21","author":"Eser","year":"2015","journal-title":"Inflamm. Bowel. Dis."},{"key":"10.1016\/j.bcp.2017.07.016_b0455","doi-asserted-by":"crossref","first-page":"427125","DOI":"10.1155\/2015\/427125","article-title":"Pathophysiological role of extracellular purinergic mediators in the control of intestinal inflammation","volume":"2015","author":"Kurashima","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0460","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11302-014-9439-y","article-title":"P2X7 receptor of rat dorsal root ganglia is involved in the effect of moxibustion on visceral hyperalgesia","volume":"11","author":"Liu","year":"2015","journal-title":"Purinergic Signal."},{"issue":"19","key":"10.1016\/j.bcp.2017.07.016_b0465","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1111\/bph.12802","article-title":"Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies","volume":"171","author":"Jim\u00e9nez","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0470","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2016.08.029","article-title":"Purinergic signaling in kidney disease","volume":"91","author":"Menzies","year":"2017","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0475","doi-asserted-by":"crossref","first-page":"C463","DOI":"10.1152\/ajpcell.00245.2014","article-title":"P2X7 receptor inhibition protects against ischemic acute kidney injury in mice","volume":"308","author":"Yan","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2017.07.016_b0480","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1681\/ASN.2010070728","article-title":"Inhibition of the P2X7 receptor reduces cystogenesis in PKD","volume":"22","author":"Chang","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0485","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11302-017-9558-3","article-title":"Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury","volume":"13","author":"Sashindranath","year":"2017","journal-title":"Purinergic Signal."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0490","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1189\/jlb.0612284","article-title":"P2X7 receptor-mediated Nlrp3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis","volume":"93","author":"Deplano","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0495","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/hr.2011.153","article-title":"P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats","volume":"35","author":"Ji","year":"2012","journal-title":"Hypertens. Res."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0500","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/1389450111314040010","article-title":"Targeting adenosine signaling to treatment of diabetic nephropathy","volume":"14","author":"Quezada","year":"2013","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0505","doi-asserted-by":"crossref","first-page":"e97452","DOI":"10.1371\/journal.pone.0097452","article-title":"P2X7 receptor in the kidneys of diabetic rats submitted to aerobic training or to N-acetylcysteine supplementation [corrected]","volume":"9","author":"Rodrigues","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0510","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/carcin\/bgt099","article-title":"Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors","volume":"34","author":"Jelassi","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0515","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11302-013-9395-y","article-title":"Purinergic signalling in the urinary tract in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5317\/wjog.v4.i2.24","article-title":"Pioneering drugs for overactive bladder and detrusor overactivity: Ongoing research and future directions","volume":"4","author":"Sacco","year":"2015","journal-title":"World J. Obstet. Gynecol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2017.07.016_b0525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autneu.2012.10.006","article-title":"Adenosine receptor antagonism suppresses functional and histological inflammatory changes in the rat urinary bladder","volume":"171","author":"Aronsson","year":"2012","journal-title":"Auton. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0530","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1464-410X.2010.09926.x","article-title":"Therapeutic potential of purinergic signalling for diseases of the urinary tract","volume":"107","author":"Burnstock","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.bcp.2017.07.016_b0535","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11302-008-9123-1","article-title":"ATP release from the human ureter on distension and P2X3 receptor expression on suburothelial sensory nerves","volume":"4","author":"Calvert","year":"2008","journal-title":"Purinergic Signal."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0540","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11302-013-9398-8","article-title":"Purinergic signalling in the liver in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0545","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2012.06.008","article-title":"Pathological roles of purinergic signaling in the liver","volume":"57","author":"Vaughn","year":"2012","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0550","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1159\/000360498","article-title":"Purinergic signaling in liver disease","volume":"32","author":"Vaughn","year":"2014","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bcp.2017.07.016_b0555","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.phrs.2016.11.040","article-title":"Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation","volume":"117","author":"Jiang","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0560","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11302-013-9399-7","article-title":"Purinergic signalling in the reproductive system in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal."},{"issue":"2374","key":"10.1016\/j.bcp.2017.07.016_b0565","first-page":"2382","article-title":"Management of erectile function by purinergic P2 receptors in diabetic rat","volume":"181","author":"G\u00fcr","year":"2009","journal-title":"J. Urol."},{"issue":"31","key":"10.1016\/j.bcp.2017.07.016_b0570","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.2174\/138161207782341277","article-title":"Purinergic (P2) receptor control of lower genitourinary tract function and new avenues for drug action: an overview","volume":"13","author":"Gur","year":"2007","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0575","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/and.12217","article-title":"Effects of intracavernous injection of P2X3 and NK1 receptor antagonists on erectile dysfunction induced by spinal cord transection in rats","volume":"47","author":"Li","year":"2015","journal-title":"Andrologia"},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0580","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.4049\/jimmunol.179.6.3707","article-title":"Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice","volume":"179","author":"Darville","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0585","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21873\/anticanres.11345","article-title":"Purinergic receptor expression and cellular responses to purinergic agonists in human prostate cancer cells","volume":"37","author":"Lertsuwan","year":"2017","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.bcp.2017.07.016_b0590","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00432-011-1031-z","article-title":"Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway","volume":"137","author":"Aghaei","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0595","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molonc.2015.09.006","article-title":"Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells","volume":"10","author":"Azimi","year":"2016","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0600","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jid.2011.344","article-title":"Purinergic signalling in healthy and diseased skin","volume":"132","author":"Burnstock","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0605","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5314\/wjd.v5.i2.72","article-title":"P2X7 receptor in skin biology and diseases","volume":"5","author":"Geraghty","year":"2016","journal-title":"World J. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0610","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1124\/pr.113.008540","article-title":"The A3 adenosine receptor: history and perspectives","volume":"67","author":"Borea","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0615","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2340\/00015555-1931","article-title":"New drugs and treatment targets in psoriasis","volume":"95","author":"Kofoed","year":"2015","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0620","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jid.2016.08.001","article-title":"Deregulation of adenosine receptors in psoriatic epidermis: an option for therapeutic treatment","volume":"137","author":"Merighi","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0625","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jid.2016.07.028","article-title":"Adenosine A2A and A2B receptors differentially modulate keratinocyte proliferation: possible deregulation in psoriatic epidermis","volume":"137","author":"Andr\u00e9s","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0630","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/s10165-009-0251-4","article-title":"Adenosine in fibrosis","volume":"20","author":"Chan","year":"2010","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0635","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11302-016-9498-3","article-title":"Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis","volume":"12","author":"Shaikh","year":"2016","journal-title":"Purinergic Signal."},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0640","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/exd.12440","article-title":"P2Y2R activation by nucleotides promotes skin wound-healing process","volume":"23","author":"Jin","year":"2014","journal-title":"Exp. Dermatol."},{"issue":"7\u20138","key":"10.1016\/j.bcp.2017.07.016_b0645","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2009.12.010","article-title":"Comparison of the peripheral mediator background of heat injury- and plantar incision-induced drop of the noxious heat threshold in the rat","volume":"86","author":"F\u00fcredi","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2017.07.016_b0650","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.neuropharm.2013.12.005","article-title":"Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs","volume":"79","author":"Kwon","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2017.07.016_b0655","series-title":"Pharmacological Mechanisms and the Modulation of Pain","first-page":"91","article-title":"Purinergic mechanisms and pain","author":"Burnstock","year":"2016"},{"issue":"1912","key":"10.1016\/j.bcp.2017.07.016_b0660","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1098\/rsta.2009.0234","article-title":"A multi-scale view of skin thermal pain: from nociception to pain sensation","volume":"368","author":"Zhu","year":"2010","journal-title":"Philos. Transact. A Math. Phys. Eng. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0665","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jphotobiol.2011.07.009","article-title":"UV-B induced alteration in purinergic receptors and signaling on HaCaT keratinocytes","volume":"105","author":"Ruzsnavszky","year":"2011","journal-title":"J. Photochem. Photobiol. B"},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0670","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1158\/0008-5472.CAN-14-1259","article-title":"Accelerated tumor progression in mice lacking the ATP receptor P2X7","volume":"75","author":"Adinolfi","year":"2015","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2017.07.016_b0675","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JME-14-0226","article-title":"P2X7 receptors: role in bone cell formation and function","volume":"54","author":"Agrawal","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bcp.2017.07.016_b0680","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11302-013-9381-4","article-title":"Purinergic signalling in the musculoskeletal system","volume":"9","author":"Burnstock","year":"2013","journal-title":"Purinergic Signal."},{"issue":"7","key":"10.1016\/j.bcp.2017.07.016_b0685","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2174\/0929867321666141215094749","article-title":"The role of P2X receptors in bone biology","volume":"22","author":"J\u00f8rgensen","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0690","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mus.25199","article-title":"P2Y2 purinergic receptors are highly expressed in cardiac and diaphragm muscles of mdx mice, and their expression is decreased by suramin","volume":"55","author":"De Oliveira Moreira","year":"2017","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.bcp.2017.07.016_b0695","doi-asserted-by":"crossref","first-page":"e1001888","DOI":"10.1371\/journal.pmed.1001888","article-title":"P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy","volume":"12","author":"Sinadinos","year":"2015","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0700","first-page":"483","article-title":"Purinergic receptors in skeletal muscles in health and in muscular dystrophy","volume":"60","author":"Krasowska","year":"2014","journal-title":"Postepy Biochem."},{"key":"10.1016\/j.bcp.2017.07.016_b0705","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1155\/2015\/460610","article-title":"Deficits in endogenous adenosine formation by ecto-5'-nucleotidase\/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis","volume":"2015","author":"Oliveira","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bcp.2017.07.016_b0710","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/954530","article-title":"The P2X7 receptor: a key player in immune-mediated bone loss?","volume":"2014","author":"Kvist","year":"2014","journal-title":"Sci. World J."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0715","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41598-017-00139-2","article-title":"The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0720","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/jbmr.1877","article-title":"The P2Y13 receptor regulates extracellular ATP metabolism and the osteogenic response to mechanical loading","volume":"28","author":"Wang","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bcp.2017.07.016_b0725","series-title":"Osteoporosis in Orthopedics: Assessment and Therapeutic Options","first-page":"23","article-title":"Osteoclast-mediated pain in osteoporosis","author":"Iba","year":"2016"},{"key":"10.1016\/j.bcp.2017.07.016_b0730","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/ncomms15019","article-title":"Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression","volume":"8","author":"Corciulo","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2017.07.016_b0735","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3892\/ijmm.2016.2770","article-title":"Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-\u03baB pathways in the cartilage tissue of rats with osteoarthritis","volume":"38","author":"Hu","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0740","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/09537104.2015.1075493","article-title":"Platelets promote cartilage repair and chondrocyte proliferation via ADP in a rodent model of osteoarthritis","volume":"27","author":"Zhou","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.bcp.2017.07.016_b0745","article-title":"P2X3 and P2X2\/3 receptors play a crucial role in articular hyperalgesia development through inflammatory mechanisms in the knee joint experimental synovitis","author":"Teixeira","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.bcp.2017.07.016_b0750","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2017.07.016_b0755","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2012.05.008","article-title":"Chronic administration of the selective P2X3, P2X2\/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice","volume":"688","author":"Hansen","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2017.07.016_b0760","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuroscience.2015.02.011","article-title":"P2X7 receptor-mediated analgesia in cancer-induced bone pain","volume":"291","author":"Falk","year":"2015","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.bcp.2017.07.016_b0765","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/ALN.0000000000000856","article-title":"Activation of adenosine monophosphate-activated protein kinase suppresses neuroinflammation and ameliorates bone cancer pain: involvement of inhibition on mitogen-activated protein kinase","volume":"123","author":"Song","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bcp.2017.07.016_b0770","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22153","article-title":"Structural basis for subtype-specific inhibition of the P2X7 receptor","volume":"5","author":"Karasawa","year":"2016","journal-title":"Elife"},{"issue":"7498","key":"10.1016\/j.bcp.2017.07.016_b0775","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature13288","article-title":"Agonist-bound structure of the human P2Y12 receptor","volume":"509","author":"Zhang","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2017.07.016_b0780","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1469-7580.1999.19430335.x","article-title":"Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction","volume":"194","author":"Burnstock","year":"1999","journal-title":"J. Anat."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.016_b0785","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1464-410X.2008.07578.x","article-title":"Effect of extracellular ATP on the growth of hormone refractory prostate cancer in vivo","volume":"102","author":"Shabbir","year":"2008","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.016_b0790","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tips.2006.02.004","article-title":"P2 receptors and cancer","volume":"27","author":"White","year":"2006","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521730504X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521730504X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T17:00:12Z","timestamp":1750784412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521730504X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":158,"alternative-id":["S000629521730504X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.07.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of purinergic signalling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}